Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02520167
Other study ID # 15-0760
Secondary ID
Status Completed
Phase N/A
First received August 5, 2015
Last updated July 10, 2017
Start date October 2015
Est. completion date July 2017

Study information

Verified date July 2017
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will pilot and assess feasibility of a prenatal intervention for obese pregnant women based on the Diabetes Prevention Program (DPP). Intervention group participants will meet with a clinic dietitian for 15 minutes at every prenatal appointment to complete a DPP-based curriculum and receive breastfeeding education. Control group participants will receive usual prenatal care. Outcomes include reach and dose of the intervention, gestational weight gain, dietary intake, physical activity, and breastfeeding in the first 6 weeks postpartum.


Description:

This study will pilot and test feasibility of a prenatal lifestyle intervention designed to limit gestational weight gain and prevent gestational diabetes. The intervention is based on the Diabetes Prevention Program lifestyle intervention, will include prenatal breastfeeding education and online peer group support, and will be integrated into the participants' regular prenatal appointments. Women (n=24) will be enrolled in early pregnancy. After baseline assessments (demographics, maternal diet, physical activity, mental health), women randomized equally to the intervention or usual care conditions. Further data collection will occur at approximately 24 weeks gestation, 36 weeks gestation, and 6 weeks postpartum, and clinical data (weight, pregnancy and obstetric complications) will be abstracted from medical records at the end of the study. Outcomes include reach and dose of the intervention, gestational weight gain, dietary intake, physical activity, and breastfeeding in the first 6 weeks postpartum. The investigators hypothesize that the intervention will reduce gestational weight gain, improve maternal dietary intake, increase total energy expenditure, and increase breastfeeding exclusivity in the first 6 weeks postpartum.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date July 2017
Est. primary completion date July 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Singleton pregnancies of <12 weeks gestation

- Pre-pregnant body mass index >=30

- Speak and understand English

- Plan to continue care at the clinic through pregnancy and postpartum

Exclusion Criteria:

- Pre-existing diabetes

- History of serious chronic illnesses

- History of prior gestational diabetes

- Prior delivery at <37 weeks gestation

- Prior delivery of infant weighing <2500g

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Dietary and Lifestyle Counseling
Dietary and lifestyle education; Peer group support.

Locations

Country Name City State
United States Denver Health Eastside Family Health Center Denver Colorado

Sponsors (2)

Lead Sponsor Collaborator
University of Colorado, Denver Denver Health and Hospital Authority

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gestational weight gain Weight change from pre-pregnancy to time of delivery 40 weeks
Secondary Maternal fruit intake Change in daily servings of fruit from early pregnancy to mid-pregnancy, late pregnancy, and postpartum Assessed from 12 weeks gestation through 6 weeks postpartum
Secondary Maternal vegetable intake Change in daily servings of vegetables from early pregnancy to mid-pregnancy, late pregnancy, and postpartum Assessed from 12 weeks gestation through 6 weeks postpartum
Secondary Maternal whole grains intake Change in daily servings of whole grains from early pregnancy to mid-pregnancy, late pregnancy, and postpartum Assessed from 12 weeks gestation through 6 weeks postpartum
Secondary Maternal solid fats intake Change in daily servings of solid fats from early pregnancy to mid-pregnancy, late pregnancy, and postpartum Assessed from 12 weeks gestation through 6 weeks postpartum
Secondary Maternal added sugars intake Change in daily servings of added sugars from early pregnancy to mid-pregnancy, late pregnancy, and postpartum Assessed from 12 weeks gestation through 6 weeks postpartum
Secondary Maternal physical activity Change in total estimated energy expenditure from early pregnancy to mid-pregnancy, late pregnancy, and postpartum Assessed from 12 weeks gestation through 6 weeks postpartum
Secondary Exclusive breastfeeding Measured as exclusive breastfeeding (no formula, no complementary foods) in the first 6 weeks postpartum Assessed at 6 weeks postpartum
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed NCT02408315 - Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE) Phase 3